Clinical Trial Update: 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 4-Methylumbelliferone as a treatment for chronic hepatitis B and chronic hepatitis C is ongoing, with current status listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C

Drugs mentioned

• 4-Methylumbelliferone (4-methylumbelliferone)

Snippet

Sponsor: MTmedical Institute of Health | Conditions: Chronic Hepatitis C, Chronic Hepatitis B | Phase 2 | Status: UNKNOWN